| Tretinoin | Approved Investigational Nutraceutical | PSMB10 | 5699 |
upregulated | Tretinoin results in increased expression of PSMB10 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PSMB2 | 5690 |
upregulated | Tretinoin results in increased expression of PSMB2 mRNA | 1p34.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PSMB8 | 5696 |
upregulated | Tretinoin results in increased expression of PSMB8 mRNA | 6p21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | PSMB9 | 5698 |
upregulated | Tretinoin results in increased expression of PSMB9 mRNA | 6p21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | PSMC2 | 5701 |
downregulated | Tretinoin results in decreased expression of PSMC2 mRNA | 7q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PSMD11 | 5717 |
downregulated | Tretinoin results in decreased expression of PSMD11 mRNA | 17q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PSMD7 | 5713 |
upregulated | Tretinoin results in increased expression of PSMD7 mRNA | 16q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PSME2 | 5721 |
upregulated | Tretinoin results in increased expression of PSME2 mRNA | 14q12 | |
| Tretinoin | Approved Investigational Nutraceutical | PSMG4 | 389362 |
downregulated | Tretinoin results in decreased expression of PSMG4 mRNA | 6p25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PTAR1 | 375743 |
upregulated | Tretinoin results in increased expression of PTAR1 mRNA | 9q21.12 | |
| Tretinoin | Approved Investigational Nutraceutical | PTEN | 5728 |
upregulated | Tretinoin results in increased expression of PTEN mRNA | 10q23.31 | |
| Tretinoin | Approved Investigational Nutraceutical | PTGES | 9536 |
upregulated | Tretinoin results in increased expression of PTGES mRNA | 9q34.11 | |
| Tretinoin | Approved Investigational Nutraceutical | PTGIS | 5740 |
downregulated | Tretinoin results in decreased expression of PTGIS mRNA | 20q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | PTGS1 | 5742 |
downregulated | Tretinoin metabolite results in decreased expression of PTGS1 mRNA | 9q33.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PTGS1 | 5742 |
upregulated | Tretinoin results in increased expression of PTGS1 mRNA | 9q33.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PTGS2 | 5743 |
upregulated | Tretinoin metabolite results in increased expression of PTGS2 mRNA | 1q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PTGS2 | 5743 |
downregulated | Tretinoin results in decreased expression of PTGS2 mRNA | 1q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PTGS2 | 5743 |
upregulated | Tretinoin results in increased expression of PTGS2 mRNA | 1q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PTK2 | 5747 |
upregulated | Tretinoin results in increased expression of PTK2 mRNA | 8q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PTK2B | 2185 |
upregulated | Tretinoin results in increased expression of PTK2B mRNA | 8p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PTK7 | 5754 |
upregulated | Tretinoin results in increased expression of PTK7 mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PTMA | 5757 |
downregulated | Tretinoin results in decreased expression of PTMA mRNA | 2q37.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PTN | 5764 |
downregulated | Tretinoin results in decreased expression of PTN mRNA | 7q33 | |
| Tretinoin | Approved Investigational Nutraceutical | PTN | 5764 |
upregulated | Tretinoin results in increased expression of PTN mRNA | 7q33 | |
| Tretinoin | Approved Investigational Nutraceutical | PTOV1 | 53635 |
upregulated | Tretinoin results in increased expression of PTOV1 mRNA | 19q13.33 | |